Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)
Alexion Pharmaceuticals was off to an incredibly strong day in the market today. However, minutes ago, the stock started to take a dive. Below, we’ll talk about what we’re seeing from the stock, why, and what we should be watching with regard to ALXN ahead.
What We’re Seeing From ALXN
As mentioned above, Alexion Pharmaceuticals was off to an incredibly strong day in the market today, trading nearly 10% higher at its peak. However, minutes ago, things started to change in a big way as the stock started spiking downward. Currently (12:17), ALXN is trading at $132.46 per share after a gain of $4.94 per share (3.87%) thus far today.
Why The Stock Is Spiking Downward
In the beginning of the day, the stock was spiking on the delay of its quarterly earnings report as rumors started to surface that an acquisition may be on the horizon. However, the opinion on ALXN seems to be changing quickly. As more and more investors realize that the 10-Q delay doesn’t paint the picture of merger and acquisition news, the stock is taking a dive.
What To Watch Ahead
Moving forward, the story surrounding Alexion Pharmaceuticals is likely to be interesting, to say the least. However, I wouldn’t be jumping on this too quickly. The truth is that there could be several reasons for the delay in the ALXN quarterly report. Some of these reasons may be very positive, but others are very negative. So, we’ll be watching the story as it evolves and bringing the news to you ahead!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!
[Image Courtesy of Wikimedia]